Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2012's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
Premium Content
Top News
Top 10 News Items for 05/20 to 05/24: A True Fed Tapering?, Japan's Nikkei Blasted, Dimons are Forever
Valeant (VRX) Continues Deal Hunt; Close to Buying Bausch & Lomb for $9B
A.G. Lafley Returns as President/CEO of Procter & Gamble (PG)
Send to a Friend
Font Size:
Increase
Decrease
ARIA and MRK Related Headlines
Go Back
Jun 5, 2012 04:41PM
UPDATE: Merck (MRK) Gets CRL from FDA for Ridaforolimus; Cannot Approve NDA in Current Form (ARIA)
ARIA and MRK Related Press Releases
Go Back
ARIA and MRK Related SEC Filings
Go Back
